Abstract
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis.
Joachim R Kalden, Christian Antoni, Jose M Alvaro-Gracia, Bernard Combe, Paul Emery, Joel M Kremer, C Vibeke Strand, Piet Van Riel and Josef S Smolen
The Journal of Rheumatology August 2005, 32 (8) 1620-1631;
Joachim R Kalden
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
Christian Antoni
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
Jose M Alvaro-Gracia
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
Bernard Combe
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
Paul Emery
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
Joel M Kremer
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
C Vibeke Strand
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
Piet Van Riel
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
Josef S Smolen
Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.
In this issue
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis.
Joachim R Kalden, Christian Antoni, Jose M Alvaro-Gracia, Bernard Combe, Paul Emery, Joel M Kremer, C Vibeke Strand, Piet Van Riel, Josef S Smolen
The Journal of Rheumatology Aug 2005, 32 (8) 1620-1631;